Drug Shortage Report for JAMP-RANITIDINE

Last updated on 2021-04-07 History
Report ID 96241
Drug Identification Number 02463717
Brand name JAMP-RANITIDINE
Common or Proper name Ranitidine
Company Name JAMP PHARMA CORPORATION
Market Status DORMANT
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-07
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-04-07 French Compare
v7 2021-04-07 English Compare
v6 2020-06-19 French Compare
v5 2020-06-19 English Compare
v4 2020-02-18 French Compare
v3 2020-02-18 English Compare
v2 2019-10-11 French Compare
v1 2019-10-11 English Compare

Showing 1 to 8 of 8